Curry Barker’s Obsession has passed $500 million at the worldwide box office, a threshold that puts the independently made horror film among the year’s most commercially striking theatrical releases. Box Office Mojo lists the Focus Features release at $501.66 million globally, with $263.45 million from domestic theaters and $238.21 million internationally.
The result extends an already exceptional run for a film reported to have cost about $750,000 to make. More than three months after its May 15 U.S. opening, Obsession has moved from festival discovery to a global box-office event, illustrating how a compact genre picture can still break through a theatrical market often dominated by established franchises and studio-scale campaigns.
A milestone confirmed by two current tallies
There is a small difference in the precise worldwide total reported by major trackers, but no dispute about the milestone itself. On Aug. 24, Bloody Disgusting reported that the film had reached $501.60 million worldwide, citing a completed U.S. run of $263.45 million. Box Office Mojo’s current worldwide figure is $501,663,715, or $67,000 higher.
Such minor gaps are common in box-office reporting, where trackers and distributors can update international receipts on different schedules. The useful common denominator is the rounded figure: Obsession is now above $500 million worldwide. The domestic number is identical in the two tallies, while the variation sits in the international aggregate.
The film reached the mark after accelerating sharply through the summer. On June 7, The Hollywood Reporter said it had crossed $200 million globally and had become Focus Features’ highest-grossing release worldwide. Two days later, Deadline placed its global gross above $229.3 million. The latest totals mean the film added more than $270 million after that early-June benchmark.
From Toronto acquisition to a global theatrical run
Obsession premiered at the Toronto International Film Festival in September 2025, before Focus acquired rights in October. Deadline reported that the distributor paid more than $15 million for North America and much of the international market. The acquisition gave Focus an unusually high-profile specialty release whose subsequent performance far exceeded the conventional commercial expectations attached to a festival-bought horror title.
The reported production cost is a crucial part of the story, though it should not be confused with a profit calculation. The approximately $750,000 figure cited by Deadline and The Hollywood Reporter would place the film’s worldwide ticket sales at roughly 667 times that reported production budget. But theatrical grosses are not the same as studio or distributor revenue: theaters retain a share of ticket sales, and marketing, distribution, financing and participant costs are separate from the making of the film. The calculation instead shows the scale of the audience response relative to the film’s reported production footprint.
The film’s path has also been unusually sustained. Its box-office story was not limited to a large opening weekend or a quick domestic burst. At the current tally, international receipts account for about 47.5% of worldwide sales, based on Box Office Mojo’s figures. That split helps explain how a title with a strong U.S. run could continue building toward $500 million after its domestic business had largely finished.
Record claims require different levels of certainty
Bloody Disgusting characterized Obsession as the first original film released in the 2020s to pass $500 million worldwide. It also relayed comparisons attributed to TheWrap, including claims that the film is the highest-grossing original movie since the pandemic, the top-grossing festival acquisition and the highest-grossing film made for less than $1 million.
Those comparisons may be useful descriptions of the film’s stature, but they depend on definitions and a complete set of historical box-office data not laid out in the available reports. “Original,” for instance, can be classified differently when a film draws on preexisting concepts, formats or other underlying material. “Festival acquisition” can similarly vary according to territory rights and deal structure. The directly verifiable achievement is simpler: the film has exceeded $500 million worldwide, and it had already set Focus Features’ worldwide-gross record by early June.
For Focus, the outcome gives the specialty distributor a rare theatrical success at a scale more usually associated with major studio event films. For the broader horror market, it is another reminder that a distinctive, comparatively inexpensive film can become a worldwide draw when festival attention, distribution support and audience interest align—without its production scale resembling its eventual box-office reach.